La Jolla Institute for Allergy and Immunology Seqster to Support Asthma Study at La Jolla Institute of Immunology A new partnership and licensing agreement will help the research institute aggregate genotype and phenotype data for the NIH-funded PreCISE Network asthma program. Variants Impacting Gene Expression of Immune Cell Types Emerge From Study The researchers hope the datasets from their study can help to explain the effects of disease-associated variants on specific cell types of the immune system. Single-Cell Transcriptome Sequencing Uncovers New Immune Precursor Cell A La Jolla Institute for Allergy and Immunology-led team sequenced the transcriptomes of thousands of CD4+ T cells and compared their expression patterns. Vaccine Development Stands to Benefit From Results of New Human Immune System Sequencing Project Premium The Human Immunome Program, which is part of the Human Vaccines Project, eventually plans to profile B-cell and T-cell receptors in more than 1,000 individuals. La Jolla Institute for Allergy Joins Sanford Consortium The La Jolla Institute for Allergy and Immunology (LIAI) has joined the Sanford Consortium for Regenerative Medicine, a new facility in San Diego that is set to open in November and will focus on stem cell research. Oct 14, 2010 NIH Awards $12.6M to La Jolla Institute to Build RNAi Screening Center Premium Mar 4, 2009 MedImmune Inks Exclusive License Agreement with La Jolla Institute for Asthma Discovery Premium Breaking News UPDATE: Immunexpress Receives FDA 510(k) Clearance for Sepsis Assay DNA Script Receives CE Mark for Syntax Enzymatic DNA Synthesis Platform Exact Sciences, Pfizer End Cologuard Copromotion Agreement Genetron Health Q3 Revenues up 36 Percent, Firm Announces AstraZeneca MRD Partnership BioMark Diagnostics, AstraZeneca, Pfizer, Others Partner in Lung Cancer Screening Project Akoya Receives CLIA Certification for Biopharma Solutions Laboratory The Scan Looking for Omicron NPR reports that SARS-CoV-2 testing in the US has gotten better but also that some experts say more needs to be done to better track the Omicron variant. Holmes Alleges Abuse The Associated Press reports that Theranos' Elizabeth Holmes has testified at her wire fraud trial that her business and romantic partner abused her. Bit More Diverse, But More to Do While Black and Hispanic patients are more likely to participate in cancer clinical trials than previously, they are still underrepresented, according to US News & World Report. PNAS Papers on Yeast Gene Silencing, Zika Virus Inhibition, Immunoglobulin Hypermutation In PNAS this week: gene silencing in Saccharomyces cerevisiae, possible neuroprotective role for SHFL in a mouse model of Zika virus infection, and more.